Advertisement
Now in our tenth year on the internet! Search for nursing homes in the U.S. at the Medicare website! | News from governmental sources FDA issues alert on potential dangers of unproven treatment for multiple sclerosis
May 10, 2012 -- The U.S. Food and Drug Administration is alerting health care professionals and patients about injuries and death associated with the use of an experimental procedure sometimes called "liberation therapy" or the "liberation procedure" to treat chronic cerebrospinal venous insufficiency (CCSVI). Some researchers believe that CCSVI, which is characterized by a narrowing (stenosis) of veins in the neck and chest, may cause multiple sclerosis (MS) or may contribute to the progression of the disease by impairing blood drainage from the brain and upper spinal cord. However, studies exploring a link between MS and CCSVI are inconclusive, and the criteria used to diagnose CCSVI have not been adequately established ... read more U.S. Marshals seize ultrasound gel product at a New Jersey company April 18, 2012 -- U.S. Marshals, acting at the request of the Food and Drug Administration, have seized Other-Sonic Generic Ultrasound Transmission Gel located at Pharmaceutical Innovations Inc. in Newark, N.J., after an FDA analysis found that product samples contained dangerous bacteria. The seizure included all lots of the gel product manufactured between June 2011 and December 2011.Until they were seized, the products were held under embargo by the New Jersey Department of Health and Senior Services at FDA's request. Under the Federal Food, Drug, and Cosmetic Act, the seized gel is adulterated, because product samples were contaminated with two strains of bacteria, Pseudomonas aeruginosa and Klebsiella oxytoca. The gel is also misbranded because it is dangerous to health when used in the manner suggested in the labeling. These bacteria pose serious risks of infection to individuals exposed to the product. ... read more Another counterfeit cancer medicine found in U.S. - Illegal practice puts patients at risk April 3, 2012 -- FDA lab tests have confirmed that a counterfeit version of Roche's Altuzan 400mg/16ml (bevacizumab), an injectable cancer medication, found in the U.S. contains no active ingredient. Even if the identified drugs were not counterfeit, Altuzan is not approved by FDA for use in the United States (it is an approved drug in Turkey) ... read more Links for information
![]() ![]() |
© 2001 - 2012 MeDiCaLeSe.org
Online since July 11, 2001